Could This Biosimilar Drug Candidate Be a Winner for Amgen?
Amgen''s biosimilar drug is close to stealing away sales from AstraZeneca''s rare disease drug called Soliris.
Could This Biosimilar Drug Candidate Be a Winner for Amgen?
Amgen''s biosimilar drug is close to stealing away sales from AstraZeneca''s rare disease drug called Soliris.